Adjuvant combination immunotherapy (BCG and levamisole) in malignant melanoma.
D001500:BCG Vaccine / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D007978:Levamisole / Q000008:administration & dosage*; D008297:Male; D008545:Melanoma / Q000628:therapy*; D012878:Skin Neoplasms / Q000628:therapy*
D001500:BCG Vaccine; D007978:Levamisole